DNA 복구 약물 시장 보고서(2026년)

DNA repair drugs are therapeutic agents developed to support or restore the body's natural DNA repair mechanisms within cells. These drugs are used in the treatment of various conditions, including cancer, by helping repair genetic damage and enhancing the effectiveness of other therapies such as chemotherapy and radiation.

The main types of DNA repair drugs include olaparib, rucaparib, niraparib, talazoparib, and others. Olaparib is a medication used to treat adults with certain types of prostate cancer, pancreatic cancer, breast cancer, ovarian cancer, fallopian tube cancer, or primary peritoneal cancer, either as a standalone therapy or in combination with other drugs. These medications are distributed through hospital pharmacies, retail pharmacies, and other channels, and are used for the treatment of ovarian cancer, fallopian tube cancer, peritoneal cancer, breast cancer, and other indications.

Tariffs have influenced the dna repair drugs market by increasing costs for imported active pharmaceutical ingredients, specialized intermediates, and advanced manufacturing equipment used in oncology drug production. These impacts are most pronounced across branded parp inhibitors, combination therapies, and hospital pharmacy distribution channels, with north america and europe particularly affected due to complex cross-border supply chains. Tariff pressures have also slowed pricing flexibility and delayed product availability in some regions. However, tariffs are encouraging localized manufacturing, regional sourcing strategies, and domestic pharmaceutical investments, which may strengthen long-term supply resilience and innovation capacity.

The dna repair drugs market research report is one of a series of new reports from The Business Research Company that provides dna repair drugs market statistics, including dna repair drugs industry global market size, regional shares, competitors with a dna repair drugs market share, detailed dna repair drugs market segments, market trends and opportunities, and any further data you may need to thrive in the dna repair drugs industry. This dna repair drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dna repair drugs market size has grown rapidly in recent years. It will grow from $13 billion in 2025 to $15.55 billion in 2026 at a compound annual growth rate (CAGR) of 19.6%. The growth in the historic period can be attributed to rising global cancer incidence, increased adoption of chemotherapy and radiation, strong clinical success of parp inhibitors, growth in oncology drug approvals, expansion of hospital-based cancer treatment infrastructure.

The dna repair drugs market size is expected to see rapid growth in the next few years. It will grow to $32.21 billion in 2030 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to increasing precision medicine adoption, growing investment in dna damage response research, rising demand for maintenance cancer therapies, expansion of targeted oncology pipelines, improved diagnostic identification of genetic mutations. Major trends in the forecast period include expansion of parp inhibitor-based therapies, rising use of combination cancer treatments, increased focus on personalized oncology drugs, growth in maintenance therapy applications, advancements in next-generation ddr inhibitors.

The increasing prevalence of cancer is anticipated to drive the expansion of the DNA repair drug market in the coming years. Cancer is a group of diseases that can arise in almost any organ or tissue when abnormal cells grow uncontrollably, extend beyond their normal boundaries, and spread to other organs or invade nearby tissues. The rise in cancer incidence is largely attributed to factors such as smoking, radiation exposure, carcinogenic substances, obesity, and genetic mutations. DNA repair drugs work by disrupting the ability of cancer cells to repair damaged DNA, thereby preventing further replication and leading to cancer cell death. For example, in July 2024, according to the Australian Institute of Health and Welfare, an Australia-based government agency, the number of cancer cases diagnosed in Australia increased from 160,570 in 2022 to 164,694 in 2023, indicating a significant year-on-year rise. Consequently, the growing burden of cancer is contributing to the growth of the DNA repair drug market.

Major companies operating in the DNA repair drug market are concentrating on the development of innovative therapies such as oral poly ADP-ribose polymerase (PARP) inhibitors. Oral PARP inhibitors are medications administered by mouth that specifically target the PARP enzyme involved in DNA repair mechanisms. For instance, in June 2023, Pfizer Inc., a US-based global pharmaceutical company, announced approval from the U.S. Food and Drug Administration for TALZENNA (talazoparib). TALZENNA became the first and only PARP inhibitor approved for use in combination with the established standard therapy XTANDI for adult patients with metastatic castration-resistant prostate cancer carrying homologous recombination repair gene mutations. TALZENNA works by inhibiting PARP enzyme activity and trapping PARP at sites of DNA damage, which suppresses cancer cell growth and induces cell death.

In October 2024, Merck & Co. acquired Modifi Biosciences for approximately $30 million. Through this acquisition, Merck aims to strengthen its oncology pipeline by gaining access to a novel class of small-molecule therapies that exploit DNA repair deficiencies in cancer cells. Modifi Biosciences is a US-based company focused on developing DNA-modification-enabled cancer therapeutics that selectively target tumors lacking the DNA repair protein MGMT.

Major companies operating in the dna repair drugs market are Pfizer Inc., Johnson & Johnson Private Limited, AbbVie Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Regeneron Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Jiangsu HengRui Medicine Co. Ltd., Genentech Inc., ClovisOncology Inc., Karyopharm Therapeutics Inc., Repare Therapeutics Inc., C4 Therapeutics Inc., Precision BioSciences, Artios Pharma Limited, FoRx Therapeutics AG, Onxeo SA

North America was the largest region in the DNA repair drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dna repair drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dna repair drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The DNA repair drugs market consists of sales of veliparib, methyl methane sulfonate, mitomycin C, and cisplatin. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

DNA Repair Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses dna repair drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dna repair drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dna repair drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Drug Type: Olaparib; Rucaparib; Niraparib; Talazoparib; Other Drugs
• 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Other Distribution Channels
• 3) By Application: Ovarian Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Breast Cancer; Other Applications
• Subsegments:
• 1) By Olaparib: Tablets; Capsules; Combination Therapies
• 2) By Rucaparib: Tablets; Monotherapy; Combination with Other Cancer Treatments
• 3) By Niraparib: Capsules; Extended-Release Formulations; Maintenance Therapy Applications
• 4) By Talazoparib: Capsules; Combination with Immunotherapy; High-Dose and Low-Dose Options
• 5) By Other Drugs: Experimental PARP Inhibitors; Generic and Biosimilar Versions; Next-Generation DNA Damage Response (DDR) Inhibitors
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson Private Limited; AbbVie Inc.; Bayer AG; Novartis AG; Bristol-Myers Squibb Company; AstraZeneca PLC; Sanofi S.A.; GlaxoSmithKline plc.; Takeda Pharmaceutical Company Limited; Gilead Sciences Inc.; Amgen Inc.; Merck KGaA; Regeneron Pharmaceuticals Inc.; Ono Pharmaceutical Co. Ltd.; Jiangsu HengRui Medicine Co. Ltd.; Genentech Inc.; ClovisOncology Inc.; Karyopharm Therapeutics Inc.; Repare Therapeutics Inc.; C4 Therapeutics Inc.; Precision BioSciences; Artios Pharma Limited; FoRx Therapeutics AG; Onxeo SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. DNA Repair Drugs Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global DNA Repair Drugs Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. DNA Repair Drugs Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global DNA Repair Drugs Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Sustainability, Climate Tech & Circular Economy
• 4.2. Major Trends
  • 4.2.1 Expansion Of Parp Inhibitor-Based Therapies
  • 4.2.2 Rising Use Of Combination Cancer Treatments
  • 4.2.3 Increased Focus On Personalized Oncology Drugs
  • 4.2.4 Growth In Maintenance Therapy Applications
  • 4.2.5 Advancements In Next-Generation Ddr Inhibitors

5. DNA Repair Drugs Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Oncology Specialty Clinics
• 5.3 Cancer Research Institutes
• 5.4 Academic Medical Centers
• 5.5 Specialty Pharmacies

6. DNA Repair Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global DNA Repair Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global DNA Repair Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global DNA Repair Drugs Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global DNA Repair Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global DNA Repair Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global DNA Repair Drugs Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. DNA Repair Drugs Market Segmentation

• 9.1. Global DNA Repair Drugs Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Olaparib, Rucaparib, Niraparib, Talazoparib, Other Drugs
• 9.2. Global DNA Repair Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
• 9.3. Global DNA Repair Drugs Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Breast Cancer, Other Applications
• 9.4. Global DNA Repair Drugs Market, Sub-Segmentation Of Olaparib, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tablets, Capsules, Combination Therapies
• 9.5. Global DNA Repair Drugs Market, Sub-Segmentation Of Rucaparib, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Tablets, Monotherapy, Combination with Other Cancer Treatments
• 9.6. Global DNA Repair Drugs Market, Sub-Segmentation Of Niraparib, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Capsules, Extended-Release Formulations, Maintenance Therapy Applications
• 9.7. Global DNA Repair Drugs Market, Sub-Segmentation Of Talazoparib, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Capsules, Combination with Immunotherapy, High-Dose and Low-Dose Options
• 9.8. Global DNA Repair Drugs Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Experimental PARP Inhibitors, Generic and Biosimilar Versions, Next-Generation DNA Damage Response (DDR) Inhibitors

10. DNA Repair Drugs Market Regional And Country Analysis

• 10.1. Global DNA Repair Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global DNA Repair Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific DNA Repair Drugs Market

• 11.1. Asia-Pacific DNA Repair Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China DNA Repair Drugs Market

• 12.1. China DNA Repair Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India DNA Repair Drugs Market

• 13.1. India DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan DNA Repair Drugs Market

• 14.1. Japan DNA Repair Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia DNA Repair Drugs Market

• 15.1. Australia DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia DNA Repair Drugs Market

• 16.1. Indonesia DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea DNA Repair Drugs Market

• 17.1. South Korea DNA Repair Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan DNA Repair Drugs Market

• 18.1. Taiwan DNA Repair Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia DNA Repair Drugs Market

• 19.1. South East Asia DNA Repair Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe DNA Repair Drugs Market

• 20.1. Western Europe DNA Repair Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK DNA Repair Drugs Market

• 21.1. UK DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany DNA Repair Drugs Market

• 22.1. Germany DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France DNA Repair Drugs Market

• 23.1. France DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy DNA Repair Drugs Market

• 24.1. Italy DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain DNA Repair Drugs Market

• 25.1. Spain DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe DNA Repair Drugs Market

• 26.1. Eastern Europe DNA Repair Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia DNA Repair Drugs Market

• 27.1. Russia DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America DNA Repair Drugs Market

• 28.1. North America DNA Repair Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA DNA Repair Drugs Market

• 29.1. USA DNA Repair Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada DNA Repair Drugs Market

• 30.1. Canada DNA Repair Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America DNA Repair Drugs Market

• 31.1. South America DNA Repair Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil DNA Repair Drugs Market

• 32.1. Brazil DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East DNA Repair Drugs Market

• 33.1. Middle East DNA Repair Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa DNA Repair Drugs Market

• 34.1. Africa DNA Repair Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa DNA Repair Drugs Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. DNA Repair Drugs Market Regulatory and Investment Landscape

36. DNA Repair Drugs Market Competitive Landscape And Company Profiles

• 36.1. DNA Repair Drugs Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. DNA Repair Drugs Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. DNA Repair Drugs Market Company Profiles
  • 36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

37. DNA Repair Drugs Market Other Major And Innovative Companies

• Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi S.A., GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Amgen Inc., Merck KGaA, Regeneron Pharmaceuticals Inc., Ono Pharmaceutical Co. Ltd., Jiangsu HengRui Medicine Co. Ltd., Genentech Inc., ClovisOncology Inc., Karyopharm Therapeutics Inc., Repare Therapeutics Inc.

38. Global DNA Repair Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The DNA Repair Drugs Market

40. DNA Repair Drugs Market High Potential Countries, Segments and Strategies

• 40.1 DNA Repair Drugs Market In 2030 - Countries Offering Most New Opportunities
• 40.2 DNA Repair Drugs Market In 2030 - Segments Offering Most New Opportunities
• 40.3 DNA Repair Drugs Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer